ConductScience.org, home

Paper39129161

Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-inflammatory Pathways.

Pasricha C and 5 others. Curr Pharm Biotechnol, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-inflammatory Pathways. Papers, record 39129161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39129161

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-inflammatory Pathways.
PubMed
Journal
Curr Pharm Biotechnol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
2.1, provisional
iCite
Revised in PubMed
2025-11-12
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pasricha CChiraghttps://orcid.org/0009-0000-2180-3556
2Bansal NNancy
3Kaur RRupinder
4Kumari PPratima
5Jangra SSarita
6Singh RRavinder

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InflammationMajor topic
ImmunoglobulinsMajor topic
Anti-Inflammatory AgentsMajor topic
Humans
Animals

References201

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12186517Antibody: the flexible adaptor molecule.Trends Biochem Sci1990https://conductscience.org/library/papers/2186517PubMed
237830631Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use.Cells2023https://conductscience.org/library/papers/37830631PubMed
328898770Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach.Int Immunopharmacol2017https://conductscience.org/library/papers/28898770PubMed
433494384Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity.Int J Mol Sci2021https://conductscience.org/library/papers/33494384PubMed
528814461Subcutaneous immunoglobulin in myasthenia gravis exacerbation: A prospective, open-label trial.Neurology2017https://conductscience.org/library/papers/28814461PubMed
625667260Intravenous immunoglobulin as clinical immune-modulating therapy.CMAJ2015https://conductscience.org/library/papers/25667260PubMed
728967695Intravenous immunoglobulin for the treatment of childhood encephalitis.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28967695PubMed
826384525Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence.Autoimmun Rev2016https://conductscience.org/library/papers/26384525PubMed
94162102Physicochemical properties of reaginic antibody. 3. Further studies on the reaginic antibody in gamma-A-globulin preparations.J Allergy1966https://conductscience.org/library/papers/4162102PubMed
1010592235The Protein Data Bank.Nucleic Acids Res2000https://conductscience.org/library/papers/10592235PubMed
1131544870IgG Antibody 3D Structures and Dynamics.Antibodies (Basel)2018https://conductscience.org/library/papers/31544870PubMed
1226497515Fcγ receptor pathways during active and passive immunization.Immunol Rev2015https://conductscience.org/library/papers/26497515PubMed
1326764357Influence of immunoglobulin isotype on therapeutic antibody function.Blood2016https://conductscience.org/library/papers/26764357PubMed
1420041883The other side of immunoglobulin G: suppressor of inflammation.Clin Exp Immunol2010https://conductscience.org/library/papers/20041883PubMed
1528951559Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health.Sci Rep2017https://conductscience.org/library/papers/28951559PubMed
1623808883The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies.Exp Dermatol2013https://conductscience.org/library/papers/23808883PubMed
1722922409Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1.Nat Med2012https://conductscience.org/library/papers/22922409PubMed
1824016253Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation.J Proteome Res2013https://conductscience.org/library/papers/24016253PubMed
1925761865Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.J Proteome Res2015https://conductscience.org/library/papers/25761865PubMed
2026200652Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome.Arthritis Rheumatol2015https://conductscience.org/library/papers/26200652PubMed

See all 201 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42325772Effects of high-dose intravenous immunoglobulin on efficacy, inflammatory markers, and pulmonary function in adults with severe acute viral pneumonia.Am J Transl Res2026https://conductscience.org/library/papers/42325772PubMed
40794949Differential causal networks highlight sex-based differences in human tissues.Brief Bioinform2025https://conductscience.org/library/papers/40794949PubMed
40565297A Novel Hybrid Peptide VLP-Aβ Efficiently Regulates Immunity by Stimulating Myeloid Differentiation Protein and Activating the NF-κB Pathway.Int J Mol Sci2025https://conductscience.org/library/papers/40565297PubMed
40211143Immune status assessment based on plasma proteomics with meta graph convolutional networks.BMC Genomics2025https://conductscience.org/library/papers/40211143PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FCAR2204PubTator's text mininghttps://conductscience.org/library/genes/2204NCBI Gene
FCGRT2217PubTator's text mininghttps://conductscience.org/library/genes/2217NCBI Gene
IGHE3497PubTator's text mininghttps://conductscience.org/library/genes/3497NCBI Gene
IGHG33502PubTator's text mininghttps://conductscience.org/library/genes/3502NCBI Gene
LOC102723407102723407PubTator's text mininghttps://conductscience.org/library/genes/102723407NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39129161

GET https://conductscience.org/api/papers/v1/39129161/references?page=2